XSpray Pharma AB (publ)
F:6XP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
XSpray Pharma AB (publ)
F:6XP
|
SE |
|
Capricor Therapeutics Inc
F:4LN2
|
US |
|
Saipem SpA
F:SPE1
|
IT |
|
thyssenkrupp AG
F:TKA
|
DE |
|
A
|
Advanced Micro Devices Inc
MIL:1AMD
|
US |
|
D
|
Diageo PLC
BMV:DEON
|
UK |
|
C
|
Cencora Inc
XMUN:ABG
|
US |
|
V
|
Vector Group Ltd
DUS:VGR
|
US |
|
Stellantis NV
PAR:STLAP
|
NL |
|
M
|
Mondelez International Inc
F:KTF
|
US |
|
H
|
Harmony Gold Mining Company Ltd
SWB:HAM
|
ZA |
|
A
|
Anglo American Platinum Ltd
XMUN:RPHA
|
ZA |
|
C
|
Commerzbank AG
BMV:CBKN
|
DE |
|
N
|
Nippon Television Holdings Inc
TSE:9404
|
JP |
|
D
|
Diageo PLC
SWB:GUI
|
UK |
|
W
|
WSOL PCL
SET:WSOL
|
TH |
|
Firstcash Holdings Inc
F:FF60
|
US |
|
PKSHA Technology Inc
F:762
|
JP |
|
I
|
ITV PLC
XMUN:IJ7
|
UK |
|
Draegerwerk AG & Co KGaA
F:DRW8
|
DE |
|
A
|
Aflac Inc
XMUN:AFL
|
US |
|
I
|
ImmunoGen Inc
F:IMU
|
US |
|
F
|
Ford Motor Co
XMUN:FMC1
|
US |
Bankruptcy Probability
XSpray Pharma AB (publ)'s probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
XSpray Pharma AB (publ) Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| SE |
|
XSpray Pharma AB (publ)
STO:XSPRAY
|
1.2B SEK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
406.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
186.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
155.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
118.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
64.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
50.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
XSpray Pharma AB (publ)'s probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, XSpray Pharma AB (publ) has total debt of 20.4m SEK. This includes both short-term (0 SEK) and long-term (20.4m SEK) debt.
You can find a full breakdown on its Balance Sheet.
